Cancer patients treated with chemotherapy. Follow-up examination after chemotherapy for other conditions
Conditions
Interventions
Intervention 1: Patients of the treatment group will receive Curcumin capsule (600 mg) every 12 hours for 9 weeks. Intervention 2: Patients in the control group will receive placebo every 12 hours, fo
Treatment - Drugs
Placebo
Patients of the treatment group will receive Curcumin capsule (600 mg) every 12 hours for 9 weeks.
Patients in the control group will receive placebo every 12 hours, for 9 weeks.
Sponsors
Baghiyyatollah University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: Cancer patients treated between May 2016 and December 2016; Ten days after the last surgery; able to move or perform their normal activities; Exclusion criteria: Failure to return to the center during the course of treatment; Failure to cooperate in blood tests; Patient's death.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Liver damage. Timepoint: Baseline, three months after the start of the intervention. Method of measurement: Questionnaire.;Renal damage. Timepoint: Baseline, three months after the start of the intervention. Method of measurement: Questionnaire.;Changes in blood enzymes. Timepoint: Baseline, three months after the start of the intervention. Method of measurement: Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduce the quality of life. Timepoint: Baseline, three months after the start of the intervention. Method of measurement: Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr.YunesPanahi
Baqiyatallah University of Medical Sciences
Outcome results
None listed